Lucintel's latest market report analyzed that human microbiome provides attractive opportunities in the healthcare industry. The human microbiome market is expected to reach $1.9 billion by 2028 with a CAGR of 18.6%. In this market, probiotics is the largest segment by product, whereas infectious disease is largest by disease type. Usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/human-microbiome-market.aspx
Based on product, the human microbiome market is segmented into prebiotics, probiotics, food, medical food, and drugs. The probiotics segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.
Browse in-depth TOC on “Human Microbiome Market”
99 – Tables
119 – Figures
209 – Pages
The Human Microbiome Market is marked by the presence of several big and small players. Some of the prominent players offering human microbiome include Enterome, Seres Therapeutics, 4D Pharma, DuPont, Vedanta Biosciences, Osel, Merck & Co., Second Genome, and Metabiomics Corporation.
Request Sample Report:
https://www.lucintel.com/human-microbiome-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.